Skip to main content

Table 1 Comparison of the matching factors of the unmatched and matched cohorts

From: Treatment outcomes of re-irradiation using stereotactic ablative radiotherapy to lung: a propensity score matching analysis

Characteristics

Re-irradiation SABR group (N = 20)

Initial SABR group (unmatched cohort) (N = 316)

Initial SABR group (matched cohort) (N = 60)

Number

P-value*

SMD*

Number

P-value*

SMD*

Age (> 75 years)

9 (45.0%)

135 (42.7%)

1.000

0.046

24 (40.0%)

0.896

0.101

Lung cancer primary

15 (75.0%)

222 (70.3%)

0.842

0.107

48 (80.0%)

0.875

0.120

Underlying pulmonary disease

8 (40.0%)

81 (25.6%)

0.265

0.302

24 (40.0%)

1.000

 < 0.001

Tumor size

(> 2 cm)

11 (55.0%)

133 (42.1%)

0.369

0.261

33 (55.0%)

1.000

 < 0.001

Tumor location (lower lobe)

9 (45.0%)

142 (44.9%)

1.000

0.001

27 (45.0%)

1.000

 < 0.001

  1. *Compared with re-irradiation SABR group
  2. SABR, stereotactic ablative body radiotherapy; SMD, standardized mean difference